Integra Lifesciences Holdings (IART) EV to CFO (2009 - 2026)

Integra Lifesciences Holdings has disclosed EV to CFO across 18 years of filings, most recently posting 49.24 for Q2 2026.

• In Q2 2026, EV to CFO fell 37.48% year-over-year to 49.24; the TTM figure through Jun 2026 stood at 13.16 (up 32.79% YoY), while the FY2025 annual figure was 13.98, up 22.38% from the prior year.
• EV to CFO came in at 49.24 for Q2 2026 at Integra Lifesciences Holdings, up from 47.67 in the prior quarter.
• In the past five years, EV to CFO ranged from a high of 168.02 in Q1 2023 to a low of 127.53 in Q1 2025.
• Average EV to CFO over 5 years is 60.33, with a median of 51.36 recorded in 2023.
• Year-over-year, EV to CFO slumped 194.32% in 2025 and jumped 137.38% in 2026.
• Over 5 years, EV to CFO stood at 48.29 in 2022, then gained by 9.18% to 52.72 in 2023, then sank by 44.76% to 29.12 in 2024, then surged by 104.64% to 59.6 in 2025, then declined by 17.39% to 49.24 in 2026.
• Per Business Quant data, the three most recent EV to CFO figures were 49.24 in Q2 2026, 47.67 in Q1 2026, and 59.6 in Q4 2025.